Laluna, Judy Mae S.

HRN: 07-88-10  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/05/2023
CEFUROXIME 750MG (VIAL)
12/05/2023
12/11/2023
IV
750mg
Q8h
UTI
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Urinary Tract    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: No 

Intervention



Type of Intervention done:

                    

           


Acceptance: